Portfolio Companies

  • AI/ML Ops
    Architecture, Engineering, and Construction
    B2B GTM
    B2C MarTech & Customer Support
    BioTech/Therapeutics
    Consumer
    Cybersecurity
    Data & Data Mgmt.
    DevOps
    eCommerce Enablement
    Education
    Energy & Climate
    Finance & Accounting
    Financial Services
    Gaming
    Government
    Healthcare
    Human Capital
    IT Mgmt
    Legal & Compliance
    Manufacturing
    Marketplace
    Other Vertical Market SaaS
    Payments
    Product & Process Management
    Real Estate
    Supply Chain & Logistics
    Web3
  • North America
    Africa
    Western Europe
    Eastern Europe
    Asia Pacific
    Israel
    South America
  • Current Investment
    Prior Investment

Limerick, No Data Available, Ireland

Amsterdam, No Data Available, Netherlands

Tel Aviv, No Data Available, Israel

Bonn, No Data Available, Germany

Miami, Florida, U.S.

San Francisco, California, U.S.

Insight Partners is an awesome firm that shares many of our values, and we’ve been grateful to have them as partners on this journey of building a great company based on a great product.
Eran Zinman
Co-Founder & CEO Monday.com*

London, No Data Available, U.K.

Lehi, Utah, U.S.

Farmington, Utah, U.S.

Espressive logo

San Francisco, California, U.S.

Wilmington, North Carolina, U.S.

San Francisco, California, U.S.

Idoven is a health technology company advancing early detection and precision medicine for cardiovascular diseases. Idoven’s AI-powered platform, WillemTM, delivers substantial improvements to the speed, consistency and accuracy of electrocardiogram (ECG) interpretation and prediction. Its powerful, proprietary AI algorithms, which work with existing ECG devices, are also being applied to develop disease biomarkers towards patient identification, risk stratification and prognosis, as well as drug cardiac safety monitoring. Idoven partners with leading medical device and pharmaceutical companies on AI-driven innovations to develop a new standard of cardiovascular care. Idoven has been awarded with numerous distinctions for its AI technology in Europe and the US, including the prestigious Horizon 2020 (H2020), the European Innovation Council (EIC) Accelerator award from the European Commission and Healthy Longevity Catalyst Award from the U.S. National Academy of Medicine. The company is backed by top tier investors including Insight Partners, Northzone and Accel Starter programme, Wayra (Telefónica), leading business angels and EIT Health. For more information on Idoven, visit idoven.ai or follow us on LinkedIn @idoven.

Investment Team Scott Barclay Matt Gatto Ryan Hinkle
Sectors Healthcare Pharma
Tags Applied AI
Status Current Investment